Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
This report elaborates on the current development of the Postmenopausal Vaginal Atrophy Treatment industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Teva Pharmaceutical
Shionogi
Pfizer
Allergan
By Type:
Tablets
Creams
Rings
Patches
By Application:
Topical Estrogen
Non-hormonal
Systemic Estrogen
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Postmenopausal Vaginal Atrophy Treatment Market Overview 2018-2029
-
1.1 China Postmenopausal Vaginal Atrophy Treatment Industry Development Overview
-
1.2 China Postmenopausal Vaginal Atrophy Treatment Industry Development History
-
1.3 China Postmenopausal Vaginal Atrophy Treatment Industry Market Size (2018-2029)
-
1.4 China Postmenopausal Vaginal Atrophy Treatment Market Analysis by Type from Production Side
-
1.4.1 China Postmenopausal Vaginal Atrophy Treatment Production Volume, Production Value and Growth Rate of Tablets (2018-2029)
-
1.4.2 China Postmenopausal Vaginal Atrophy Treatment Production Volume, Production Value and Growth Rate of Creams (2018-2029)
-
1.4.3 China Postmenopausal Vaginal Atrophy Treatment Production Volume, Production Value and Growth Rate of Rings (2018-2029)
-
1.4.4 China Postmenopausal Vaginal Atrophy Treatment Production Volume, Production Value and Growth Rate of Patches (2018-2029)
-
1.5 China Postmenopausal Vaginal Atrophy Treatment Market Analysis by Application from Consumption End
-
1.5.1 China Postmenopausal Vaginal Atrophy Treatment Sales Volume, Sales Value and Growth Rate of Topical Estrogen (2018-2029)
-
1.5.2 China Postmenopausal Vaginal Atrophy Treatment Sales Volume, Sales Value and Growth Rate of Non-hormonal (2018-2029)
-
1.5.3 China Postmenopausal Vaginal Atrophy Treatment Sales Volume, Sales Value and Growth Rate of Systemic Estrogen (2018-2029)
-
1.6 China Postmenopausal Vaginal Atrophy Treatment Market Analysis by Region
-
1.6.1 North China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
Chapter 2 China Postmenopausal Vaginal Atrophy Treatment Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Postmenopausal Vaginal Atrophy Treatment Market Status and Competition at home and abroad in 2023
-
2.2.2 China Postmenopausal Vaginal Atrophy Treatment Market Status and Competition Analysis in 2023
-
2.2.3 China Postmenopausal Vaginal Atrophy Treatment Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Postmenopausal Vaginal Atrophy Treatment Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Postmenopausal Vaginal Atrophy Treatment Industry Development
Chapter 3 Postmenopausal Vaginal Atrophy TreatmentIndustry Chain Analysis
-
3.1 Postmenopausal Vaginal Atrophy Treatment Industry Chain
-
3.2 Postmenopausal Vaginal Atrophy Treatment Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Postmenopausal Vaginal Atrophy Treatment Market
-
3.3 Postmenopausal Vaginal Atrophy Treatment Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Postmenopausal Vaginal Atrophy Treatment Market
Chapter 4 China Postmenopausal Vaginal Atrophy Treatment Market, by Type
-
4.1 China Postmenopausal Vaginal Atrophy Treatment Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Postmenopausal Vaginal Atrophy Treatment Total Production Volume and Growth Rate from Production Side
-
4.5 China Postmenopausal Vaginal Atrophy Treatment Production Volume and Growth Rate, by Type
-
4.5.1 China Postmenopausal Vaginal Atrophy Treatment Production Volume and Growth Rate of Tablets
-
4.5.2 China Postmenopausal Vaginal Atrophy Treatment Production Volume and Growth Rate of Creams
-
4.5.3 China Postmenopausal Vaginal Atrophy Treatment Production Volume and Growth Rate of Rings
-
4.5.4 China Postmenopausal Vaginal Atrophy Treatment Production Volume and Growth Rate of Patches
Chapter 5 China Postmenopausal Vaginal Atrophy Treatment Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Postmenopausal Vaginal Atrophy Treatment Total Market Size and Growth Rate from Consumption End
-
5.5 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate, by Application
-
5.5.1 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Topical Estrogen
-
5.5.2 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Non-hormonal
-
5.5.3 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Systemic Estrogen
Chapter 6 China Postmenopausal Vaginal Atrophy Treatment Market, by Region
-
6.1 China Postmenopausal Vaginal Atrophy Treatment Production Volume and Production Value, by Region
-
6.2 China Postmenopausal Vaginal Atrophy Treatment Sales Volume and Sales Value, by Region
Chapter 7 North China Postmenopausal Vaginal Atrophy Treatment Market Analysis
-
7.1 North China Postmenopausal Vaginal Atrophy Treatment Market, by Type
-
7.2 North China Postmenopausal Vaginal Atrophy Treatment Market, by Application
Chapter 8 Central China Postmenopausal Vaginal Atrophy Treatment Market Analysis
-
8.1 Central China Postmenopausal Vaginal Atrophy Treatment Market, by Type
-
8.2 Central China Postmenopausal Vaginal Atrophy Treatment Market, by Application
Chapter 9 South China Postmenopausal Vaginal Atrophy Treatment Market Analysis
-
9.1 South China Postmenopausal Vaginal Atrophy Treatment Market, by Type
-
9.2 South China Postmenopausal Vaginal Atrophy Treatment Market, by Application
Chapter 10 East China Postmenopausal Vaginal Atrophy Treatment Market Analysis
-
10.1 East China Postmenopausal Vaginal Atrophy Treatment Market, by Type
-
10.2 East China Postmenopausal Vaginal Atrophy Treatment Market, by Application
Chapter 11 Northeast China Postmenopausal Vaginal Atrophy Treatment Market Analysis
-
11.1 Northeast China Postmenopausal Vaginal Atrophy Treatment Market, by Type
-
11.2 Northeast China Postmenopausal Vaginal Atrophy Treatment Market, by Application
Chapter 12 Southwest China Postmenopausal Vaginal Atrophy Treatment Market Analysis
-
12.1 Southwest China Postmenopausal Vaginal Atrophy Treatment Market, by Type
-
12.2 Southwest China Postmenopausal Vaginal Atrophy Treatment Market, by Application
Chapter 13 Northwest China Postmenopausal Vaginal Atrophy Treatment Market Analysis
-
13.1 Northwest China Postmenopausal Vaginal Atrophy Treatment Market, by Type
-
13.2 Northwest China Postmenopausal Vaginal Atrophy Treatment Market, by Application
Chapter 14 Company Profiles
-
14.1 Teva Pharmaceutical
-
14.1.1 Teva Pharmaceutical Company Profile
-
14.1.2 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Shionogi
-
14.2.1 Shionogi Company Profile
-
14.2.2 Shionogi Postmenopausal Vaginal Atrophy Treatment Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Pfizer
-
14.3.1 Pfizer Company Profile
-
14.3.2 Pfizer Postmenopausal Vaginal Atrophy Treatment Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Allergan
-
14.4.1 Allergan Company Profile
-
14.4.2 Allergan Postmenopausal Vaginal Atrophy Treatment Market Performance
-
14.4.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Postmenopausal Vaginal Atrophy Treatment Industry Research Conclusions
-
15.2 Postmenopausal Vaginal Atrophy Treatment Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Postmenopausal Vaginal Atrophy Treatment Industry Market Size (2018-2029)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Volume, Production Value and Growth Rate of Tablets (2018-2029)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Volume, Production Value and Growth Rate of Creams (2018-2029)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Volume, Production Value and Growth Rate of Rings (2018-2029)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Volume, Production Value and Growth Rate of Patches (2018-2029)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Sales Volume, Sales Value and Growth Rate of Topical Estrogen (2018-2029)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Sales Volume, Sales Value and Growth Rate of Non-hormonal (2018-2029)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Sales Volume, Sales Value and Growth Rate of Systemic Estrogen (2018-2029)
-
Figure North China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
Figure Central China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
Figure South China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
Figure East China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate from 2018-2029
-
Figure Postmenopausal Vaginal Atrophy Treatment Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Share by Type in 2018
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Share by Type in 2023
-
Figure China Postmenopausal Vaginal Atrophy Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Volume and Growth Rate of Tablets (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Volume and Growth Rate of Creams (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Volume and Growth Rate of Rings (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Volume and Growth Rate of Patches (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Share by Application in 2018
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Share by Application in 2023
-
Figure China Postmenopausal Vaginal Atrophy Treatment Total Market Size and Growth Rate from Consumption End
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Topical Estrogen (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Non-hormonal (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Systemic Estrogen (2018-2023)
-
Table China Postmenopausal Vaginal Atrophy Treatment Production Volume by Region (2018-2023)
-
Table China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Region (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Region (2018-2023)
-
Table China Postmenopausal Vaginal Atrophy Treatment Production Value by Region (2018-2023)
-
Table China Postmenopausal Vaginal Atrophy Treatment Production Value Share by Region (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Value Share by Region (2018-2023)
-
Table China Postmenopausal Vaginal Atrophy Treatment Sales Volume by Region (2018-2023)
-
Table China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Region (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Region (2018-2023)
-
Table China Postmenopausal Vaginal Atrophy Treatment Sales Value by Region (2018-2023)
-
Table China Postmenopausal Vaginal Atrophy Treatment Sales Value Share by Region (2018-2023)
-
Figure China Postmenopausal Vaginal Atrophy Treatment Sales Value Share by Region (2018-2023)
-
Table North China Postmenopausal Vaginal Atrophy Treatment Production Volume by Type (2018-2023)
-
Table North China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Figure North China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Table North China Postmenopausal Vaginal Atrophy Treatment Sales Volume by Application (2018-2023)
-
Table North China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Figure North China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Table Central China Postmenopausal Vaginal Atrophy Treatment Production Volume by Type (2018-2023)
-
Table Central China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Figure Central China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Table Central China Postmenopausal Vaginal Atrophy Treatment Sales Volume by Application (2018-2023)
-
Table Central China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Figure Central China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Table South China Postmenopausal Vaginal Atrophy Treatment Production Volume by Type (2018-2023)
-
Table South China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Figure South China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Table South China Postmenopausal Vaginal Atrophy Treatment Sales Volume by Application (2018-2023)
-
Table South China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Figure South China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Table East China Postmenopausal Vaginal Atrophy Treatment Production Volume by Type (2018-2023)
-
Table East China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Figure East China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Table East China Postmenopausal Vaginal Atrophy Treatment Sales Volume by Application (2018-2023)
-
Table East China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Figure East China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Table Northeast China Postmenopausal Vaginal Atrophy Treatment Production Volume by Type (2018-2023)
-
Table Northeast China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Figure Northeast China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Table Northeast China Postmenopausal Vaginal Atrophy Treatment Sales Volume by Application (2018-2023)
-
Table Northeast China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Table Southwest China Postmenopausal Vaginal Atrophy Treatment Production Volume by Type (2018-2023)
-
Table Southwest China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Figure Southwest China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Table Southwest China Postmenopausal Vaginal Atrophy Treatment Sales Volume by Application (2018-2023)
-
Table Southwest China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Table Northwest China Postmenopausal Vaginal Atrophy Treatment Production Volume by Type (2018-2023)
-
Table Northwest China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Figure Northwest China Postmenopausal Vaginal Atrophy Treatment Production Volume Share by Type (2018-2023)
-
Table Northwest China Postmenopausal Vaginal Atrophy Treatment Sales Volume by Application (2018-2023)
-
Table Northwest China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Postmenopausal Vaginal Atrophy Treatment Sales Volume Share by Application (2018-2023)
-
Table Teva Pharmaceutical Company Profile
-
Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Revenue, Price and Gross (2018-2023)
-
Table Shionogi Company Profile
-
Table Shionogi Postmenopausal Vaginal Atrophy Treatment Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Postmenopausal Vaginal Atrophy Treatment Revenue, Price and Gross (2018-2023)
-
Table Allergan Company Profile
-
Table Allergan Postmenopausal Vaginal Atrophy Treatment Revenue, Price and Gross (2018-2023)
-
